Steven R. Abel

845 total citations
33 papers, 633 citations indexed

About

Steven R. Abel is a scholar working on Geriatrics and Gerontology, Pharmacology and Ophthalmology. According to data from OpenAlex, Steven R. Abel has authored 33 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Geriatrics and Gerontology, 6 papers in Pharmacology and 6 papers in Ophthalmology. Recurrent topics in Steven R. Abel's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Pharmaceutical studies and practices (5 papers) and Retinal Diseases and Treatments (4 papers). Steven R. Abel is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Pharmaceutical studies and practices (5 papers) and Retinal Diseases and Treatments (4 papers). Steven R. Abel collaborates with scholars based in United States, Canada and Türkiye. Steven R. Abel's co-authors include Bruce A. Mueller, Sarah J. Miller, Nicholas G. Popovich, Kirk E. Evoy, Daniel J. Wilson, Roy B. Jones, Julie S. Ivy, Søren J. Sørensen, Mayu O. Frank and A I Hartstein and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Steven R. Abel

30 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven R. Abel United States 15 138 130 118 115 96 33 633
Daoud Al‐Badriyeh Qatar 16 58 0.4× 136 1.0× 127 1.1× 29 0.3× 63 0.7× 95 805
S. E. Tett Australia 20 65 0.5× 328 2.5× 138 1.2× 14 0.1× 205 2.1× 51 1.2k
Mauro Venegoni Italy 18 115 0.8× 23 0.2× 40 0.3× 25 0.2× 353 3.7× 41 862
Giampaolo Velo Italy 14 191 1.4× 8 0.1× 79 0.7× 112 1.0× 315 3.3× 33 923
Aqil Mohammad Daher Malaysia 14 43 0.3× 94 0.7× 105 0.9× 10 0.1× 18 0.2× 46 667
Pengxiang Zhou China 11 85 0.6× 18 0.1× 39 0.3× 15 0.1× 48 0.5× 29 455
Ishak A. Mansi United States 19 50 0.4× 26 0.2× 86 0.7× 10 0.1× 62 0.6× 77 1.2k
Carlton K.K. Lee United States 16 96 0.7× 7 0.1× 43 0.4× 98 0.9× 151 1.6× 30 845
Mirjana Huić Croatia 15 37 0.3× 44 0.3× 107 0.9× 8 0.1× 32 0.3× 42 726
George A. Davis United States 15 22 0.2× 16 0.1× 43 0.4× 41 0.4× 84 0.9× 51 885

Countries citing papers authored by Steven R. Abel

Since Specialization
Citations

This map shows the geographic impact of Steven R. Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Abel more than expected).

Fields of papers citing papers by Steven R. Abel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Abel. The network helps show where Steven R. Abel may publish in the future.

Co-authorship network of co-authors of Steven R. Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Steven R. Abel. A scholar is included among the top collaborators of Steven R. Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven R. Abel. Steven R. Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sypher, Beverly Davenport, et al.. (2020). Engineering Faculty As Academic Change Leaders. 15.488.1–15.488.8.
2.
Smith, Kathryn N., et al.. (2016). A simulation approach for evaluating medication supply chain structures. International Journal of Systems Science Operations & Logistics. 4(1). 13–26. 5 indexed citations
3.
Wilson, Daniel J., et al.. (2015). Comparing the Efficacy of Ophthalmic NSAIDs in Common Indications. Annals of Pharmacotherapy. 49(6). 727–734. 30 indexed citations
4.
Evoy, Kirk E. & Steven R. Abel. (2013). Ranibizumab: The First Vascular Endothelial Growth Factor Inhibitor Approved for the Treatment of Diabetic Macular Edema. Annals of Pharmacotherapy. 47(6). 811–818. 9 indexed citations
5.
Patel, Sheetal, et al.. (2011). A Virtual Clean Room to Teach USP 797 Regulations for Intravenous Medications. American Journal of Pharmaceutical Education. 75(1). 7–7. 21 indexed citations
6.
Abel, Steven R., et al.. (2008). Interdisciplinary Analysis of Chemotherapy Preparation at a Pediatric Hospital. Journal for Healthcare Quality. 30(5). 13–19. 3 indexed citations
7.
Galt, Kimberly A., et al.. (2006). Developing Clinical Practice Skills for Pharmacists. Annals of Pharmacotherapy. 40(7-8). 1480–1481. 2 indexed citations
8.
Popovich, Nicholas G. & Steven R. Abel. (2002). The need for a broadened definition of faculty scholarship and creativity. American Journal of Pharmaceutical Education. 66(1). 59–65. 26 indexed citations
9.
Sowinski, Kevin M., Steven R. Abel, William R. Clark, & Bruce A. Mueller. (1999). Effect of Gender on the Pharmacokinetics of Ofloxacin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(4). 442–446. 17 indexed citations
10.
Abel, Steven R., et al.. (1999). Cost impact of Pharm.D. candidates’ drug therapy recommendations. American Journal of Health-System Pharmacy. 56(9). 882–884. 28 indexed citations
11.
Frank, Mayu O., et al.. (1998). Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program.. PubMed. 5(4). 180–8. 77 indexed citations
12.
Abel, Steven R., et al.. (1996). Comparison Oftheocular Beta-Blockers. Annals of Pharmacotherapy. 30(1). 43–54. 42 indexed citations
13.
Abel, Steven R., et al.. (1996). Therapeutic-interchange algorithm for multiple drug classes. American Journal of Health-System Pharmacy. 53(11). 1295–1296. 5 indexed citations
14.
Lucas, B. Daniel, et al.. (1995). Terfenadine pharmacokinetics in breast milk in lactating women. Clinical Pharmacology & Therapeutics. 57(4). 398–402. 24 indexed citations
15.
Mueller, Bruce A., et al.. (1994). Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin. Antimicrobial Agents and Chemotherapy. 38(9). 2101–2105. 52 indexed citations
16.
Abel, Steven R., et al.. (1991). Evaluation of an Imipenem/Cilastatin Target Drug Program. DICP. 25(4). 348–350. 11 indexed citations
17.
Mueller, Bruce A. & Steven R. Abel. (1990). Impact of College of Pharmacy-Based Educational Services within the Hospital. DICP. 24(4). 422–425. 27 indexed citations
18.
Abel, Steven R., et al.. (1989). Lipid Lowering Agents1. Seminars in Dialysis. 2(3). 186–189. 2 indexed citations
19.
Abel, Steven R., et al.. (1988). Medication Error Prevention by Pharmacists. American Journal of Health-System Pharmacy. 45(9). 1902–1903. 80 indexed citations
20.
Abel, Steven R., et al.. (1981). Color-keyed patient medication counseling system. American Journal of Health-System Pharmacy. 38(5). 704–705. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026